Insider Transactions Reported by 14 Insiders of Upstream Bio, Inc.

Symbol
UPB on Nasdaq
Location
Waltham, MA

There are no Buy or Sell transactions made by insiders since 06 Feb 2025

Upstream Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Everett Rand Sutherland Chief Executive Officer, Director $2,036,250 02 Jan 2026
Aaron Deykin Chief Medical Officer $911,724 02 Jan 2026
MICHAEL GRAY CFO and COO $828,075 02 Jan 2026
Adam Houghton Chief Business Officer $678,750 02 Jan 2026
Allison Ambrose General Counsel $461,550 02 Jan 2026
L.P. Wellington Biomedical Innovation Master Investors (Cayman) II 10%+ Owner 15 Oct 2024
ORBIMED ADVISORS LLC Director, 10%+ Owner 15 Oct 2024
Liam Ratcliffe Director 10 Jun 2025
Marcella K. Ruddy Director 10 Jun 2025
Daniella Beckman Director 10 Jun 2025
AI Upstream LLC 10%+ Owner 15 Oct 2024
Erez Chimovits Director 10 Jun 2025
Harold Edward Fleming Director 10 Jun 2025
Ronald C. Renaud JR Director 10 Jun 2025

Recent Insider Transactions by Companies or Individuals for Upstream Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.